Clinical Trial Update: Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials compared two doses of liarozole with placebo for lamellar ichthyosis, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lamellar Ichthyosis

Drugs mentioned

• Liarozole (liarozole)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Ichthyosis, Lamellar | Phase 2, Phase 3 | Status: COMPLETED